Exit Interview
Hal Riney talks candidly to Adweek about his reluctance to retire, getting “sandbagged” by Saturn, and what still inspires and irks him about the business.
The Best Medicine
$100 Mil. Novartis Account in Play
The contenders: four New York-based agencies. The prize: the creative account for a new prescription drug. Novartis’ review is the latest entry in the hot direct-to-consumer category, which has recorded more than $1.5 billion in media and creative billings in the past year.
Rumor
WORK SMARTER - LEARN, GROW AND BE INSPIRED.
Subscribe today!
To Read the Full Story Become an Adweek+ Subscriber
Already a member? Sign in